Evaluation of serum semaphorin-3A and interleukin 6 levels in patients with neovascular age-related macular degeneration

Yükleniyor...
Küçük Resim

Tarih

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

BioMed Central Ltd

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Purpose: To determine whether serum semaphorin 3 A (Sema3A) and interleukin 6 (IL-6) play a role in the common etiopathogenesis of nAMD and nAMD-associated systemic diseases by evaluating these mediators levels. Methods: This prospective case–control study included 74 patients divided into nAMD (n = 33) and a control group (n = 41). Serum Sema3A and IL-6 levels were analyzed using the enzyme-linked immunosorbent assay. Results: The nAMD group had a statistically higher IL-6 level [5,9 (1–16,9) pg/mL], compared to the control group [1,5 (0,38 − 2,96) pg/mL] (p < 0.001). On the other hand, the Sema3A level of the nAMD group was lower at [26,3 (11,5-100) ng/mL] compared to the control group at [44,7 (16,8-100) ng/mL] (p < 0.001). The IL-6 level in the hypertension (+) group [2,5 (0,5–16,9) pg/ml] was significantly higher than that in the hypertension (-) group [1,7 (0,4–15,3) pg/ml] (p < 0.001). No significant difference was found between the hypertension (+) and hypertension (−) groups in terms of SEMA3A level. There was a negative correlation between serum SEMA3A and serum IL-6 levels of the whole participants (p < 0.001, r=-0.471). Conclusions: Decreased levels of the anti-inflammatory and anti-angiogenic mediator Sema3A and increased levels of inflammatory mediator IL-6 detected in nAMD suggest that these molecules may play a role in systemic manifestations of this syndrome, such as inflammation, cardiovascular diseases, atrial fibrillation, and Alzheimer’s disease.

Açıklama

Anahtar Kelimeler

Alzheimer’s disease, Atrial fibrillation, Cardiovascular disease, Inflammation, Interleukin 6, Neovascular age related macular degeneration, Semaphorin-3A

Kaynak

BMC Ophthalmology

WoS Q Değeri

Scopus Q Değeri

Cilt

26

Sayı

1

Künye

Okutucu, M., & Arpa, M. (2026). Evaluation of serum semaphorin-3A and interleukin 6 levels in patients with neovascular age-related macular degeneration. BMC ophthalmology, 26(1), 634. https://doi.org/10.1186/s12886-026-05128-6

Onay

İnceleme

Ekleyen

Referans Veren